D. Boral Capital Reiterates “Buy” Rating for AVITA Medical (NASDAQ:RCEL)
AVITA Medical (NASDAQ:RCEL – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at D. Boral Capital in a report issued on Tuesday,Benzinga reports. They currently have a $22.00 price objective on the stock. D. Boral Capital’s price objective would indicate a potential upside of 126.57% from the company’s previous close. RCEL has […]
AVITA Medical (NASDAQ:RCEL – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at D. Boral Capital in a report issued on Tuesday,Benzinga reports. They currently have a $22.00 price objective on the stock. D. Boral Capital’s price objective would indicate a potential upside of 126.57% from the company’s previous close. RCEL has […]
